DURECT Corporation (DRRX)
Largest Insider Buys in Sector
DRRX Stock Price History Chart
DRRX Stock Performance
About DURECT Corporation
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat …
Insider Activity of DURECT Corporation
Over the last 12 months, insiders at DURECT Corporation have bought $0 and sold $0 worth of DURECT Corporation stock.
On average, over the past 5 years, insiders at DURECT Corporation have bought $327,332 and sold $229,329 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 9,412 shares for transaction amount of $8,000 was made by Robertson Judith J. () on 2022‑08‑18.
List of Insider Buy and Sell Transactions, DURECT Corporation
| 2022-08-18 | 9,411.76 0.0041% | $0.85 | $8,000 | -41.00% | ||||
| 2022-08-17 | 8,130 0.0035% | $0.85 | $6,906 | -42.30% | ||||
| 2022-08-12 | 25,204 0.0101% | $0.71 | $17,993 | -35.13% | ||||
| 2022-08-09 | 79,693 0.037% | $0.69 | $54,661 | -21.85% | ||||
| 2022-05-26 | 65,000 0.0285% | $0.39 | $25,597 | +30.77% | ||||
| 2022-05-24 | 5,000 0.0021% | $0.39 | $1,950 | +26.50% | ||||
| 2022-05-16 | 29,911 0.0142% | $0.41 | $12,201 | +31.58% | ||||
| 2022-05-16 | 1,800 0.0009% | $0.42 | $758 | +31.58% | ||||
| 2022-05-11 | 9,250 0.0041% | $0.40 | $3,700 | +25.00% | ||||
| 2022-05-10 | 2,339 0.001% | $0.41 | $950 | +19.05% | ||||
| 2022-05-09 | 4,250 0.0019% | $0.40 | $1,679 | +28.21% | ||||
| 2022-03-14 | 200,000 0.0937% | $0.59 | $118,000 | -6.36% | ||||
| 2021-12-10 | Sale | Chief Medical Officer | 9,000 0.0041% | $1.05 | $9,495 | |||
| 2021-12-07 | director | 20,000 0.009% | $1.02 | $20,360 | -43.00% | |||
| 2021-05-14 | Sale | Sr. VP Operations & Corp QA | 60,137 0.0003% | $1.72 | $103,682 | -34.01% | ||
| 2020-09-01 | Sale | 10 percent owner | 250,000 0.0012% | $1.68 | $420,000 | +6.89% | ||
| 2020-06-03 | Sale | Sr. VP Operations & Corp QA | 22,956 0.0001% | $2.45 | $56,284 | -18.16% | ||
| 2020-05-26 | Sale | 10 percent owner | 39,388 0.0002% | $2.50 | $98,525 | -24.06% | ||
| 2020-02-06 | 10 percent owner | 75,000 0.0004% | $1.65 | $123,623 | +23.31% | |||
| 2020-02-05 | 10 percent owner | 74,998 0.0004% | $1.69 | $126,777 | +18.24% |
Insider Historical Profitability
| First Eagle Investment Management, LLC | 10 percent owner | 26476546 85.2927% | $1.00 | 2 | 0 | +227.59% |
| Bleichroeder LP | 10 percent owner | 26414656 85.0933% | $1.00 | 3 | 2 | +19.47% |
| 21 APRIL FUND, LTD. | 10 percent owner | 22381546 72.1009% | $1.00 | 11 | 0 | +15.15% |
| THEEUWES FELIX | Chairman and CSO | 3396314 10.941% | $1.00 | 20 | 0 | +41.12% |
| SCHRECK THOMAS A | Chief Financial Officer | 1865000 6.008% | $1.00 | 2 | 0 | +101.37% |
Institutional Investor Ownership
| Ingalls Snyder Llc | $2.44M | 6.5 | 2.02M | -6.03% | -$156,542.58 | 0.11 | |
| The Vanguard Group | $1.31M | 3.48 | 1.08M | +0.72% | +$9,398.07 | <0.0001 | |
| Richmond Brothers, Inc. | $929,696.00 | 2.48 | 768,344 | +48.24% | +$302,560.42 | 1.73 | |
| Gagnon Securities | $459,959.00 | 1.23 | 380,131 | +5.97% | +$25,924.28 | 0.11 | |
| BlackRock | $416,573.00 | 1.11 | 344,275 | +1.6% | +$6,558.20 | <0.0001 |